Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer. - Nanjo S; Wu W; Karachaliou N; Blakely CM; Suzuki J; Chou YT; Ali SM; Kerr DL; Olivas VR; Shue J; Rotow J; Mayekar MK; et al. (The Journal of clinical investigation, 2022)